December 2024 – On the 06th of December, AIFA, hosted a successful GCP symposium.
Key topics discussed included updates on regulatory frameworks, the challenges posed by the incoming ICH-GCP R3, the ongoing implementation of EU Regulation 536/2014 (such as the management of Serious Breaches), data protection in clinical trials, inspection findings, the complexities of the use electronic systems in GCP clinical trials, and the evolving rules for Phase I clinical trial units.
The largely participated event was an enriching experience, providing valuable insights into the future of GCPs and the challenges on the horizon. 500+ professionals attended the Symposium with representatives from the pharmaceutical industry, CROs, and regulatory authorities who actively participated, engaging in stimulating discussions on the most relevant issues.
CROSS Research contributed to the event with the presence of Mario Corrado, Head of the Quality Assurance Unit and Maria Elisa Borroni, Sr Project Leader of the Clinical Project Unit, bringing back valuable knowledge, perspectives and strategic vision.
